Iturrieta-González Isabel, Moenen-Locoz Enzo, Hidalgo Alejandro, Vega Fernando, Cabrera Johanna, Concha Carla, Chahin Carolina, Briones Javier, Fonseca-Salamanca Flery
Department of Preclinic Sciences, Medicine Faculty, Laboratory of Infectology and Clinical Immunology, Center of Excellence in Translational Medicine-Scientific and Technological Nucleus (CEMT-BIOREN), Universidad de La Frontera, Temuco 4810296, Chile; Jeffrey Modell Center of Diagnosis and Research in Primary Immunodeficiencies, Center of Excellence in Translational Medicine, Medicine Faculty, Universidad de La Frontera, Temuco 4810296, Chile.
Chemistry and pharmacy, Universidad Autónoma de Chile, Temuco 4781151, Chile.
Parasitol Int. 2025 Feb;104:102971. doi: 10.1016/j.parint.2024.102971. Epub 2024 Sep 17.
The flagellated protozoan Lophomonas spp. is a commensal microorganism found in the intestinal tracts of cockroaches, termites, mites, and certain birds. It is the causative agent of a rare infection in humans called lophomoniasis, primarily affecting the lungs and mainly immunocompromised individuals. This parasitosis is transmitted to humans by air or through ingestion of the cystic forms of the parasite. We describe the case of a 50-year-old patient treated at a tertiary hospital in southern Chile with a history of B-cell acute lymphocytic leukemia. Radiological findings, along with increased levels of inflammatory parameters and galactomannan antigen in serum and Bronchoaveolar Lavage (BAL) raised the suspicion of a pulmonary infection. Microscopic study of BAL revealed oval to pyriform cells with mobile flagella at the anterior end, which were identified as Lophomonas spp. trophozoites, which based on EORTC/MSG criteria were associated with diagnosis of a probable pulmonary aspergillosis. Lophomoniasis was treated with metronidazole (500 mg IV every 8 h) for 14 days and pulmonary aspergillosis required a combination of fluconazole, voriconazole, anidulafungin, liposomal amphotericin B and isavuconazole. The patient responded favorably and was discharged after 95 days of hospitalization. This case highlights the importance of recognizing lophomoniasis as a parasitic infection in respiratory samples from immunocompromised patients who present pulmonary symptoms, especially those who do not respond satisfactorily to conventional antimicrobial treatments. Further research is needed to understand the various sources of Lophomonas spp. infection and develop infection prevention strategies particularly for high-risk patients.
鞭毛虫类原虫罗佛滴虫属是一种共生微生物,存在于蟑螂、白蚁、螨虫和某些鸟类的肠道中。它是人类一种罕见感染——罗佛滴虫病的病原体,主要影响肺部,且主要感染免疫功能低下的个体。这种寄生虫病通过空气或摄入寄生虫的包囊形式传播给人类。我们描述了一名50岁患者的病例,该患者在智利南部一家三级医院接受治疗,有B细胞急性淋巴细胞白血病病史。放射学检查结果,以及血清和支气管肺泡灌洗(BAL)中炎症参数和半乳甘露聚糖抗原水平升高,引发了肺部感染的怀疑。对BAL的显微镜检查发现椭圆形至梨形细胞,前端有可活动的鞭毛,被鉴定为罗佛滴虫属滋养体,根据欧洲癌症研究与治疗组织/侵袭性真菌感染协作组(EORTC/MSG)标准,这与可能的肺曲霉病诊断相关。罗佛滴虫病用甲硝唑(静脉注射500毫克,每8小时一次)治疗14天,肺曲霉病需要联合使用氟康唑、伏立康唑、阿尼芬净、脂质体两性霉素B和艾沙康唑。患者反应良好,住院95天后出院。该病例强调了在出现肺部症状的免疫功能低下患者的呼吸道样本中,将罗佛滴虫病识别为寄生虫感染的重要性,尤其是那些对传统抗菌治疗反应不佳的患者。需要进一步研究以了解罗佛滴虫属感染的各种来源,并制定特别是针对高危患者的感染预防策略。